In recent years our increased knowledge in immunity has shown that it is essential to fight off cancer and infectious diseases ; the two main causes of morbidity and mortality worldwide.
The IRCI meeting is a unique event to expose recent discoveries and exchange ideas on the immune response in both cancer and infections. The edition in 2022 will bring together international prominent scientists and clinicians to discuss their recent immunological findings in fundamental and clinical research. The goal is to keep the number of participants limited thereby driving increased discussion between leaders in the field and attendees, thus strengthening as well as defining immunological research and curative therapies in the near future.
The IRCI2022 is organized by researchers from two leading centres in Lyon, the CIRI and CRCL. This 2nd edition will have sessions in innate immunity, immuno-metabolism ; immunotherapy (epi)genetics, microbiota and infection including Covid-19.
It will be held 15th-17th June 2022 at the Charles Merieux Amphi theater, Lyon, France.
Registration as well as abstract submission can be found using the following links:
– ABSTRACT SUBMISSION
A number of short oral presentations that will be chosen from the submitted abstracts, please indicate if you would like your abstract to be considered.
Key Dates :
– Deadline for abstract submission: March 31st 2022*
– Notification of acceptance: Spring 2022
– End of early bird registration: March 31st 2022
– Conference: June 15th – 17th 2022
*If you had submitted an abstract, you can modify it until March 31st 2022.